Evicenter
P&T meetings

Emiltatug ledadotin (Emi-Le)

Adenoid cystic carcinoma with solid histology or high-grade transformation

Also known as XMT-1660
Manufacturer
Servier
Regulatory submission
Not announced
Launch
Not announced
Last updated
125 sources

Product information and disease descriptionProduct description

Product information

65 evidence topics · 28 sources

Average sales price and wholesale acquisition cost
Product price

Not applicable.

Effect of Emiltatug ledadotin on quality measures
Product-specific effect on quality measures

No evidence found.